European Urology

Editorial Board

page i

Contents

pages iv - vii

Is Maintenance Bacillus Calmette-Guérin Really Necessary?

Harry W. Herr.

25 June 2008 | pages 971 - 973

Bisphosphonates in Hormone-Refractory Prostate Cancer: Do We Have a Toxicity Problem?

Noel W. Clarke.

3 August 2008 | pages 974 - 975

Identification of High-Risk Prostate Cancer: Role of Prostate-Specific Antigen, PSA Doubling Time, and PSA velocity

Axel Heidenreich.

2 July 2008 | pages 976 - 977

Rebuttal from Authors re: Axel Heidenreich. Identification of High-Risk Prostate Cancer: Role of Prostate-Specific Antigen, PSA Doubling Time and PSA Velocity. Eur Urol 2008;54:976–7

Stacy Loeb, Anna Kettermann, Luigi Ferrucci, Patricia Landis, E. Jeffrey Metter, H. Ballentine Carter.

3 August 2008 | pages 978 - 979

Does PCA3 Help Identify Clinically Significant Prostate Cancer?

Stacy Loeb.

16 July 2008 | pages 980 - 981

  Contrast-Enhanced Ultrasound and Prostate Cancer; A Multicentre European Research Coordination Project

Margot Wink, Ferdinand Frauscher, David Cosgrove, Jean-Yves Chapelon, Leo Palwein, Michael Mitterberger, Chris Harvey, Olivier Rouvière, Jean de la Rosette, Hessel Wijkstra.

20 June 2008 | pages 982 - 993

Editorial Comment on: Contrast-Enhanced Ultrasound and Prostate Cancer; A Multicentre European Research Coordination Project

Anurag K. Singh.

page 993

  Training in Percutaneous Nephrolithotomy—A Critical Review

Jean J.M.C.H. de la Rosette, Maria P. Laguna, Jens J. Rassweiler, Pierre Conort.

28 March 2008 | pages 994 - 1003